Literature DB >> 3787505

Ocular toxicity from ethambutol.

K M Citron, G O Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3787505      PMCID： PMC460464          DOI： 10.1136/thx.41.10.737

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  6 in total

1.  CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. II. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF ETHAMBUTOL, CAPREOMYCIN AND COMPANION DRUGS, INCLUDING 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE.

Authors:  I KASS
Journal:  Tubercle       Date:  1965-06

2.  Rifampicin, ethambutol and capreomycin in pulmonary tuberculosis, previously treated with both first and second line drugs: the results of 2 years chemotherapy.

Authors:  M Aquinas; K M Citron
Journal:  Tubercle       Date:  1972-09

Review 3.  Ethambutol: a review with special reference to ocular toxicity.

Authors:  K M Citron
Journal:  Tubercle       Date:  1969-03

4.  The ocular toxicity of ethambutol and its relation to dose.

Authors:  J E Leibold
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

5.  Ocular toxicity from ethambutol.

Authors:  G J Barron; L Tepper; G Iovine
Journal:  Am J Ophthalmol       Date:  1974-02       Impact factor: 5.258

6.  Ocular toxicity following ethambutol in standard dosage.

Authors:  V K Chatterjee; D R Buchanan; A I Friedmann; M Green
Journal:  Br J Dis Chest       Date:  1986-07
  6 in total
  15 in total

1.  Current medical treatment for tuberculosis. Resources used for screening could be spent more usefully elsewhere.

Authors:  Ruth J Whitfield; Rosemary Khan; Anne Smith; Charlotte F J Rayner
Journal:  BMJ       Date:  2003-03-08

2.  Hepatotoxicity of antituberculosis drugs.

Authors:  L P Ormerod; C Skinner; J Wales
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

3.  Chemotherapy and management of tuberculosis in the United Kingdom: recommendations of the Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  1990-05       Impact factor: 9.139

4.  Exploration of the Plausible Mechanism of Ethambutol Induced Ocular Toxicity by Using Proteomics Informed Physiologically Based Pharmacokinetic (PBPK) Modeling.

Authors:  Ankit Balhara; Mayur K Ladumor; Rakesh P Nankar; Samiulla Dodheri Syed; Sanjeev Giri; Bhagwat Prasad; Saranjit Singh
Journal:  Pharm Res       Date:  2022-03-17       Impact factor: 4.200

5.  Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

6.  Management and outcome of pulmonary tuberculosis in adults notified in England and Wales in 1983. Medical Research Council Tuberculosis and Chest Diseases Unit.

Authors: 
Journal:  Thorax       Date:  1988-08       Impact factor: 9.139

Review 7.  Drug-induced ocular disorders.

Authors:  Junping Li; Ramesh C Tripathi; Brenda J Tripathi
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

8.  Management and outcome of chemotherapy for childhood tuberculosis. Medical Research Council Tuberculosis and Chest Diseases Unit.

Authors: 
Journal:  Arch Dis Child       Date:  1989-07       Impact factor: 3.791

Review 9.  Adverse effects of drugs used in the management of opportunistic infections associated with HIV infection.

Authors:  B S Peters; E Carlin; R J Weston; S J Loveless; J Sweeney; J Weber; J Main
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

10.  Longitudinal analysis of retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in ethambutol-induced optic neuropathy.

Authors:  Jinu Han; Min Kwang Byun; Junwon Lee; So Young Han; Jong Bok Lee; Sueng-Han Han
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-07       Impact factor: 3.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.